All Stories

  1. Convergent Validity of the Edinburgh Postnatal Depression Scale and the Patient Health Questionnaire (PHQ-9) in Pregnant and Postpartum Women: Their Construct Correlations with Functional Disability
  2. Serum oxytocin and corticotropin-releasing hormone levels in the third trimester of pregnancy for predicting postpartum depression in Thai women
  3. Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials
  4. Cross national comparison of medical students’ attitudes and beliefs about medical cannabis and its application for pain management
  5. A meta-analysis comparing short-term weight and cardiometabolic changes between olanzapine/samidorphan and olanzapine
  6. Blue-wavelength light therapy for post-traumatic brain injury sleepiness, sleep disturbance, depression, and fatigue: A systematic review and network meta-analysis
  7. Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis
  8. Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation for prevention and treatment of perinatal depression: a systematic review and meta-analysis of randomized-controlled trials
  9. Blue-wavelength Light Therapy for Post-traumatic Brain Injury Sleepiness, Sleep Disturbance, Depression, Fatigue: A Systematic Review and Network Meta-analysis
  10. Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand
  11. Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials
  12. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand
  13. Subjective depressive symptoms associated with pain in patients with major depressive disorder: Findings from the study on the aspect of Asian depression
  14. Perception of Stigma and Its Associated Factors Among Patients With Major Depressive Disorder: A Multicenter Survey From an Asian Population
  15. Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
  16. Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
  17. Risperidone for children and adolescents with autism spectrum disorder: a systematic review
  18. Cognitive complaints and predictors of perceived cognitive dysfunction in adults with major depressive disorder: Findings from the Cognitive Dysfunction in Asians with Depression (CogDAD) study
  19. Polydrug use among kratom users: Findings from the 2011 Thailand National Household Survey
  20. Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study
  21. Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study
  22. Depression in Kidney Transplant Recipients
  23. Internal consistency and concurrent validity of the Montreal Cognitive Assessment in individuals with major depressive disorder
  24. Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder
  25. Discrepancy between objective and subjective cognition in adults with major depressive disorder
  26. Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
  27. Delirium after a traumatic brain injury: predictors and symptom patterns
  28. Gender Differences in Depressive Symptoms in Thai Individuals with Depressed Mood and/or Anhedonia: A Differential Item Functioning Approach
  29. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials
  30. Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials
  31. Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, Asian outpatients with major depressive disorder
  32. Correlates of health-related quality of life in Thai patients with alcohol dependence
  33. Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?
  34. Routledge Handbook of Psychiatry in Asia
  35. The association of suicide risk with negative life events and social support according to gender in Asian patients with major depressive disorder
  36. Correlates of Disability in Asian Patients With Major Depressive Disorder
  37. Stressful life events preceding the onset of depression in Asian patients with major depressive disorder
  38. Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials
  39. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: A systematic review and meta-analysis of randomized-controlled trials
  40. Is Early-onset in Major Depression a Predictor of Specific Clinical Features with More Impaired Social Function?
  41. Subjective memory and concentration deficits in medication-free, non-elderly Asians with major depressive disorder: Prevalence and their correlates
  42. Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
  43. P.1.g.011 A systematic review of randomised controlled trials of lisdexamfetamine versus placebo in the treatment of adults with ADHD
  44. Relaxation for perimenopausal and postmenopausal symptoms
  45. Quetiapine for acute bipolar depression: a systematic review and meta-analysis
  46. Risk factors for an anxiety disorder comorbidity among Thai patients with bipolar disorder: results from the Thai Bipolar Disorder Registry
  47. Treatment for amphetamine dependence and abuse
  48. Suicide risk among Thai illicit drug users with and without mental/alcohol use disorders
  49. Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
  50. EPA-0239 – Quetiapine for acute bipolar depression: a systematic review and meta-analysis
  51. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: A 12-week, randomized, placebo-controlled trial
  52. Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry
  53. Effectiveness of a modified version of the applied relaxation technique in treatment of perimenopausal and postmenopausal symptoms
  54. Differences in psychiatric symptoms among Asian patients with depression: A multi-country cross-sectional study
  55. Modified relaxation technique for treating hypertension in Thai postmenopausal women
  56. Clinical features of depression in Asia: Results of a large prospective, cross-sectional study
  57. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized–controlled trials comparison with venlafaxine
  58. Time to relapse and remission of bipolar disorder: findings from a 1-year prospective study in Thailand
  59. Prevalence and predictors of pain in patients with major depressive disorder
  60. Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial
  61. Melancholic features and hostility are associated with suicidality risk in Asian patients with major depressive disorder
  62. Quetiapine versus typical antipsychotic medications for schizophrenia
  63. Addiction potential of phentermine prescribed during long-term treatment of obesity
  64. Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia
  65. 1564 – Reliability and validity of the thai version of the calgary depression scale for schizophrenia
  66. 462 – Quetiapine monotherapy in acute phase for major depressive disorder: a metaanalysis of randomized, placebo-controlled trials
  67. Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: Findings from the 2008 Thai National Mental Health survey
  68. P.6.a.007 Topiramate for alcoholism in patients recently receiving inpatient detoxification: a 12-week, randomised, placebo-controlled trial
  69. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials
  70. Cognitive changes in topiramate-treated patients with alcoholism: A 12-week prospective study in patients recently detoxified
  71. Patterns of alcohol dependence in Thai drinkers: A differential item functioning analysis of gender and age bias
  72. Bupropion for adults with attention-deficit hyperactivity disorder: Meta-analysis of randomized, placebo-controlled trials
  73. P.5.e.002 A double-blind, randomised, controlled trial of quetiapine versus haloperidol for the treatment of delirium: a preliminary report
  74. P.3.a.005 Prevalence of pain and its correlation to depression: a cross-section study in major depressive patients
  75. P.6.a.004 Endorsement patterns of DSM-IV alcohol dependence criteria in Thai women and adolescents: a differential item functioning approach
  76. S28-01 The Clinical Features of Depression in Asia: Results of a Large, Prospective, Cross-Sectional Study
  77. Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: A 12-week, randomized, controlled trial
  78. Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis
  79. Opioid antagonists for alcohol dependence
  80. Treatment for inhalant dependence and abuse
  81. Methamphetamine Psychosis in Australia, Philippines, and Thailand
  82. Relaxation for perimenopausal and postmenopausal symptoms
  83. Quetiapine versus other atypical antipsychotics for schizophrenia
  84. Quetiapine versus typical antipsychotic medications for schizophrenia
  85. Treatment for inhalant dependence and abuse
  86. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual
  87. Psychometric evaluation of the Amphetamine Cessation Symptom Assessment
  88. Quetiapine versus other atypical antipsychotics for schizophrenia
  89. The treatment of alcohol dependence
  90. Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
  91. Interventions to reduce benzodiazepine prescribing
  92. Brief Intervention for Students with Methamphetamine Use Disorders: A Randomized Controlled Trial
  93. P.5.e.002 An open-label study of quetiapine for delirium
  94. P.6.a.007 Risks and pattern of alcohol withdrawal delirium
  95. P.6.c.001 Benzodiazepines misuse in outpatients treated by internists
  96. The nature, time course and severity of methamphetamine withdrawal
  97. Benzodiazepine prescribing behaviour and attitudes: a survey among general practitioners practicing in northern Thailand
  98. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials
  99. Opioid antagonists for alcohol dependence
  100. Interventions to reduce benzodiazepine prescribing
  101. Quetiapine for schizophrenia
  102. Psychotic symptoms in methamphetamine psychotic in-patients
  103. A factor structure of methamphetamine psychotic symptoms
  104. Opioid antagonists for alcohol dependence
  105. Impact on Thai Psychiatrists of Passive Dissemination of a Clinical Practice Guideline on Prescribing Attitudes in Treatment-Resistant Schizophrenia
  106. Treatment for amphetamine withdrawal
  107. Treatment for amphetamine dependence and abuse
  108. Treatment for amphetamine psychosis
  109. HIV-Seropositive Results, Health-Related Quality of Life, and Social Support: A 24-Week Prospective Study in Thailand
  110. A factor analysis of amphetamine psychotic symptoms: Preliminary results
  111. Does the Addition of Pindolol Accelerate the Response to Electroconvulsive Therapy in Patients with Major Depression? A Double-Blind, Placebo-Controlled Pilot Study
  112. Quetiapine for schizophrenia
  113. Evaluation of three simple methods for predicting therapeutic lithium doses
  114. Seasonal variations in mood and behaviour: epidemiological findings in the north tropics
  115. Amphetamine Withdrawal: I. Reliability, Validity and Factor Structure of a Measure
  116. Amphetamine Withdrawal: II. A Placebo-Controlled, Randomised, Double-Blind Study of Amineptine Treatment
  117. Amitriptyline vs. lorazepam in the treatment of opiate-withdrawal insomnia: a randomized double-blind study
  118. COMPARATIVE STUDIES OF THE BIOLOGICAL DISTINCTION BETWEEN UNIPOLAR AND BIPOLAR DEPRESSIONS
  119. Effect of Stimulus Intensity on Prolactin and Cortisol Release Induced by Unilateral Electroconvulsive Therapy
  120. Role of serotonin3 receptors in prolactin release induced by electroconvulsive therapy: A study with ondansetron
  121. Treatment of Acute Bipolar Depression: A Review of the Literature